Circadian Genes as Therapeutic Targets in Pancreatic Cancer

Front Endocrinol (Lausanne). 2020 Sep 11:11:638. doi: 10.3389/fendo.2020.00638. eCollection 2020.

Abstract

Pancreatic cancer is one of the most lethal cancers worldwide due to its symptoms, early metastasis, and chemoresistance. Thus, the mechanisms contributing to pancreatic cancer progression require further exploration. Circadian rhythms are the daily oscillations of multiple biological processes regulated by an endogenous clock. Several evidences suggest that the circadian clock may play an important role in the cell cycle, cell proliferation and apoptosis. In addition, timing of chemotherapy or radiation treatment can influence the efficacy and toxicity treatment. Here, we revisit the studies on circadian clock as an emerging target for therapy in pancreatic cancer. We highlight those potential circadian genes regulators that are commonly affected in pancreatic cancer according to most recent reports.

Keywords: chemotherapy; circadian clock; metabolism; pancreatic cancer; precision medicine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Apoptosis / genetics
  • Cell Proliferation / genetics
  • Circadian Clocks / genetics*
  • Circadian Rhythm / genetics*
  • Disease Progression
  • Humans
  • Pancreatic Neoplasms / genetics*